- Home
- ALDX vs BACQ Comparison
ALDX vs BACQ Comparison
Compare ALDX & BACQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALDX
- BACQ
- Stock Information
- Founded
- ALDX 2004
- BACQ 2024
- Country
- ALDX United States
- BACQ United States
- Employees
- ALDX N/A
- BACQ N/A
- Industry
- ALDX Biotechnology: Pharmaceutical Preparations
- BACQ
- Sector
- ALDX Health Care
- BACQ
- Exchange
- ALDX Nasdaq
- BACQ NYSE
- Market Cap
- ALDX 304.9M
- BACQ 333.2M
- IPO Year
- ALDX 2014
- BACQ 2024
- Fundamental
- Price
- ALDX $6.58
- BACQ $10.01
- Analyst Decision
- ALDX Strong Buy
- BACQ
- Analyst Count
- ALDX 2
- BACQ 0
- Target Price
- ALDX $10.00
- BACQ N/A
- AVG Volume (30 Days)
- ALDX 666.8K
- BACQ 2.7K
- Earning Date
- ALDX 05-01-2025
- BACQ 01-01-0001
- Dividend Yield
- ALDX N/A
- BACQ N/A
- EPS Growth
- ALDX N/A
- BACQ N/A
- EPS
- ALDX N/A
- BACQ N/A
- Revenue
- ALDX N/A
- BACQ N/A
- Revenue This Year
- ALDX N/A
- BACQ N/A
- Revenue Next Year
- ALDX N/A
- BACQ N/A
- P/E Ratio
- ALDX N/A
- BACQ $111.07
- Revenue Growth
- ALDX N/A
- BACQ N/A
- 52 Week Low
- ALDX $2.75
- BACQ N/A
- 52 Week High
- ALDX $7.20
- BACQ N/A
- Technical
- Relative Strength Index (RSI)
- ALDX 53.63
- BACQ N/A
- Support Level
- ALDX $6.22
- BACQ N/A
- Resistance Level
- ALDX $6.87
- BACQ N/A
- Average True Range (ATR)
- ALDX 0.46
- BACQ 0.00
- MACD
- ALDX -0.03
- BACQ 0.00
- Stochastic Oscillator
- ALDX 60.51
- BACQ 0.00
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases. The company's product candidate, reproxalap, is a first-in-class treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer.
About BACQ BLEICHROEDER ACQUISITION CORP. I
Bleichroeder Acquisition Corp I is a blank check company.